Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Role of policosanols in the prevention and treatment of cardiovascular disease.

Varady KA, Wang Y, Jones PJ.

Nutr Rev. 2003 Nov;61(11):376-83. Review.

PMID:
14677572
2.

Policosanols as nutraceuticals: fact or fiction.

Marinangeli CP, Jones PJ, Kassis AN, Eskin MN.

Crit Rev Food Sci Nutr. 2010 Mar;50(3):259-67. doi: 10.1080/10408391003626249. Review.

PMID:
20301014
3.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
4.

Policosanol: a new treatment for cardiovascular disease?

Janikula M.

Altern Med Rev. 2002 Jun;7(3):203-17. Review.

5.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
6.
8.

Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.

Gouni-Berthold I, Berthold HK.

Am Heart J. 2002 Feb;143(2):356-65. Review.

PMID:
11835043
9.
10.

Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.

Gámez R, Máz R, Arruzazabala ML, Mendoza S, Castaño G.

Drugs R D. 2005;6(1):11-9.

PMID:
15806713
11.

Cholesterol-lowering effects of policosanol in rabbits.

Arruzazabala ML, Carbajal D, Mas R, Molina V, Valdes S, Laguna A.

Biol Res. 1994;27(3-4):205-8.

PMID:
8728832
12.

A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.

Packard C.

Atheroscler Suppl. 2006 Apr;7(1):21-9. Epub 2006 Feb 28. Review.

PMID:
16504600
13.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Review.

PMID:
18480348
14.

Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.

Dulin MF, Hatcher LF, Sasser HC, Barringer TA.

Am J Clin Nutr. 2006 Dec;84(6):1543-8.

15.
16.

Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters.

Wang YW, Jones PJ, Pischel I, Fairow C.

Lipids. 2003 Feb;38(2):165-70.

PMID:
12733749
17.

High blood cholesterol.

National Heart, Lung and Blood Institute..

Nutr Clin Care. 2003 Oct-Dec;6(3):108-14. Review.

PMID:
14979453
18.

The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.

Devroey D, Velkeniers B, Duquet W, Betz W.

Int J Cardiol. 2005 May 25;101(2):231-5.

PMID:
15882669
19.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
20.

Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.

Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.

Am Heart J. 2006 Nov;152(5):982.e1-5.

PMID:
17070175

Supplemental Content

Support Center